Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 74 results found. Search for [ COVID-19 vaccine Sanofi ]

Results 20 to 40 of 74
Reuters
September 1, 2020
Canada's two agreements follow separate deals with Pfizer Inc and Moderna Inc announced weeks ago, and are the latest example of countries rushing to secure access to vaccines


Reuters
August 29, 2020
The company is working on two of the more than 150 potential vaccines being developed across the world to tackle the COVID-19 pandemic


BusinessToday.In
August 29, 2020
COVID-19 vaccine update: The expert group of the committee, headed by Dr. VK Paul, is also in contact with domestic as well as multinational vaccine makers to understand how soon a COVID-19 vaccine will be ready


PB Jayakumar
August 14, 2020
The Western world and the big pharma are upset. They say Russia has not done adequate safety and efficacy studies and the claim is based on testing on less than 100 human volunteers


Reuters
August 12, 2020
Moderna's vaccine candidate, mRNA-1273, is one of the few that have already advanced to the final stage of testing and is on track to be completed in September


BusinessToday.In
August 12, 2020
India Stock Market Highlights Today: Bajaj Finance, followed by L&T, Bajaj Finserv, Sun Pharma, Kotak Bank, HDFC Bank and Reliance Industries were among the top losers on Sensex. On the other hand, SBI, M&M, Maruti, Bajaj Auto and Titan were among the gainers


Reuters
August 7, 2020
The latest contract is priced at roughly $10 per vaccine dose produced by J&J, or around $14.50 per dose, including a previous $456 million the U.S. government promised to J&J for vaccine development in March


Chitranjan Kumar
August 5, 2020
Share market updates and analysis for August 6: RBI policy announcement, earnings announcements and global cues to set tone for stock markets


PB Jayakumar
August 5, 2020
The vaccine, using the platform of plasmid DNA, was found to be safe and well tolerated in the Phase I, which began on 15 July, said Zydus Cadila


BusinessToday.In
August 3, 2020
Coronavirus vaccine news update: Pharmaceutical giant AstraZeneca has also said that coronavirus might require annual vaccination. CEO Pascal Soriot said that the virus is 'very unpredictable'


BusinessToday.In
August 2, 2020
Coronavirus vaccine: The Russian vaccine has raised concerns because of the speed at which it is being pushed through. However, the Russian Defence Ministry clarified that tests of the vaccine against coronavirus were conducted in full compliance with methodological regulations


Associated Press
August 1, 2020
Under White House orders, federal health agencies and the Defense Department are carrying out a plan dubbed Operation Warp Speed to deliver 300 million vaccine doses on a compressed timeline


BusinessToday.In
New Delhi, August 1, 2020
Kia Motors completes 1 lakh sales in record timeKia Motors India on Friday announced that it has crossed the 1 lakh cumulative sales milestone. With this, the Korean auto manufacturer has become the fastest automaker in India to have reached this target. It did so in just 11 months. Kia had debuted in India back in August 2019.Eight core industries' output down for 4th straight month, contracts 15% in JuneOutput of eight core industries contracted by 15 per cent in June on account of decline ...


Reuters
August 1, 2020
The Sanofi-GSK deal is for 100 million doses, at two per person, and gives the U.S. government an option to purchase an additional 500 million doses at an unspecified price


Associated Press
July 31, 2020
The United States will pay up to USD 2.1 billion for development including clinical trials, manufacturing, scale-up and delivery of its vaccine,'' the companies said in a statement. Sanofi will get the bulk of the funds


Chitranjan Kumar
July 29, 2020
Share market updates and analysis for July 30: Earnings announcements by Reliance Industries, coronavirus vaccine hopes and US Fed Reserve meeting outcome to set tone for stock markets


Reuters
July 29, 2020
Drug, priced at Rs 59 per tablet, is approved to treat mild to moderate COVID-19 and will be available at drug stores from Wednesday, says Hetero


Reuters
July 29, 2020
It is Sanofi and GSK's first deal to supply their experimental COVID-19 vaccine to a country, and British ministers have stressed the importance of securing supplies of a range of candidates early


BusinessToday.In
July 23, 2020
Coronavirus (Covid-19) Vaccine News Latest Updates: Head of WHO's emergencies programme Mike Ryan has said that while there are multiple contenders and many companies have made significant progress, the likely time for a coronavirus vaccine in the market is not before 2021


BusinessToday.In
July 18, 2020
Coronavirus vaccine news update: Goldman Sachs believes that a coronavirus vaccine could be approved by the end of the year. It predicts Moderna and Pfizer's candidates to be the first ones to pass regulatory hurdles


PAGES 2 OF 4  1234